Single dose of genetically-altered broadly-neutralizing antibodies SHIV-protective in monkeys

Researchers from the National Institute of Allergy and Infectious Diseases (NIAID; MD, USA) have reported two genetically-modified broadly-neutralizing antibodies (bNAbs) elicit long-term protection against a HIV-like virus in rhesus macaques.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment